Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.

View in: PubMed

subject areas

Adult
Aged
Antigens, CD34
Benzamides
Chromosomes, Human, Pair 22
Chromosomes, Human, Pair 8
Chromosomes, Human, Pair 9
Enzyme Inhibitors
Female
Fusion Proteins, bcr-abl
Hematopoietic Stem Cells
Humans
Imatinib Mesylate
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Male
Middle Aged
Piperazines
Protein-Tyrosine Kinases
Pyrimidines
Remission Induction
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Translocation, Genetic
Trisomy

authors with profiles

Daniel Arber